Enveric biosciences, inc.ENVB.US Overview

US StockHealthcare

(No presentation for ENVB)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ENVB Overall Performance

ENVB AI Analysis & Strategy

ENVB Recent Performance

3.76%

Enveric biosciences, inc.

0.81%

Avg of Sector

-1.14%

S&P500

ENVB PowerScanner

ENVB Key Information

ENVB Valuation Metrics

ENVB Earnings Table

ENVB Profile

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.